Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.

Cohen, M H; Broder, L E; Fossieck, B E; Ihde, D C; Minna, J D

Cohen, M H; Broder, L E; Fossieck, B E; Ihde, D C; Minna, J D.

Cancer Treat Rep ; 61(3): 489-90, 1977.

Article in En | MEDLINE | ID: mdl-194694

Subject(s)

Carcinoma, Bronchogenic/drug therapy; Carcinoma, Small Cell/drug therapy; Etoposide/administration & dosage; Lung Neoplasms/drug therapy; Podophyllotoxin/analogs & derivatives; Drug Administration Schedule; Drug Evaluation; Etoposide/adverse effects; Etoposide/therapeutic use; Humans; Leukopenia/chemically induced; Remission, Spontaneous; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Podophyllotoxin / Carcinoma, Bronchogenic / Carcinoma, Small Cell / Etoposide / Lung Neoplasms Limits: Humans Language: En Journal: Cancer Treat Rep Year: 1977 Document type: Article

Search on Google

XML

PubMed Links